Page 15 - Planmeca_Group
P. 15
Always one step ahead Prioritising safety
Unrivalled scientific knowledge and an in-depth Patient safety has always been essential to the product
understanding of clinical workflows are vital and design and development in Planmeca Group companies.
integrated parts of our product development. For example, we have been able to reduce the patient
Challenging traditional ways of working has allowed dose with up to 77% with the Planmeca Ultra Low Dose™
us to introduce groundbreaking solutions long before technology and developed different intelligent systems to
they have become mainstream. ensure that the water in our dental units is always clean.
Hygiene features are also demonstrated in our products
From vision to excellence through material selection, design and technical details.
A bold product strategy and strong investments in research UP TO
and development have resulted in industry-leading
digital solutions and a significant portfolio of patents and 10%
innovations. Every year, Planmeca Group companies invest TO R&D
up to 10% of the combined turnover in R&D.
The product development is led by strong in-house teams
of researchers and designers, including a team dedicated
to seeking out the latest emerging technologies and
implementing them in our products.
15
